This site is intended for healthcare professionals
patient receiving dialysis, hospital image
Chronic Kidney Disease Learning Zone

Expert Opinion

Read time: 35 mins
Last updated:26th Apr 2022
Published:26th Apr 2022

In our series of expert videos on chronic kidney disease (CKD), Professor Hiddo Heerspink, Professor Vlado Perkovic and Dr George Bakris highlight:

  • The unmet needs and challenges in CKD, including underdiagnosis
  • The need for early CKD diagnosis and CKD screening strategies
  • The importance of managing comorbid conditions
  • CKD treatment goals and treatment options
  • Newly approved treatments for CKD, including SGLT2 inhibitors and mineralocorticoid receptor antagonists

Professor Hiddo Heerspink

Professor Hiddo Heerspink from the University Medical Centre Groningen in the Netherlands highlights key unmet needs and clinical challenges for chronic kidney disease (CKD) and describes the DAPA-CKD trial, which led to approval of dapagliflozin for treatment of diabetic and non-diabetic kidney disease.  

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Professor Vlado Perkovic

Professor Vlado Perkovic from the University of New South Wales in Australia discusses the burden of chronic kidney disease (CKD), management of comorbid conditions and the addition of canagliflozin to the treatment armamentarium for diabetic kidney disease following the CREDENCE trial.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Dr George Bakris

Dr George Bakris from the University of Chicago Medicine in the US outlines the priorities for managing chronic kidney disease and how new treatments, including finerenone, evaluated in the FIDELIO-DKD trial, can improve outcomes for patients with diabetic kidney disease.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Welcome: